• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性支气管扩张症仍应被视为与囊性纤维化跨膜传导调节因子(CFTR)相关的疾病吗?

Should diffuse bronchiectasis still be considered a CFTR-related disorder?

作者信息

Bergougnoux Anne, Viart Victoria, Miro Julie, Bommart Sébastien, Molinari Nicolas, des Georges Marie, Claustres Mireille, Chiron Raphaël, Taulan-Cadars Magali

机构信息

Laboratoire de Génétique Moléculaire, CHRU Montpellier, Montpellier F-34093, France; INSERM U827, Laboratoire de Génétique de Maladies Rares, Montpellier F-34093, France.

INSERM U827, Laboratoire de Génétique de Maladies Rares, Montpellier F-34093, France; Université Montpellier I, UFR de Médecine, Montpellier F-34000, France.

出版信息

J Cyst Fibros. 2015 Sep;14(5):646-53. doi: 10.1016/j.jcf.2015.02.012. Epub 2015 Mar 18.

DOI:10.1016/j.jcf.2015.02.012
PMID:25797027
Abstract

BACKGROUND

Although several comprehensive studies have evaluated the role of the CFTR gene in idiopathic diffuse bronchiectasis (DB), it remains controversial.

METHODS

We analyzed the whole coding region of the CFTR gene, its flanking regions and the promoter in 47 DB patients and 47 controls. Available information about demographic, spirometric, radiological and microbiological data for the DB patients was collected. Unclassified CFTR variants were in vitro functionally assessed.

RESULTS

CFTR variants were identified in 24 DB patients and in 27 controls. DB variants were reclassified based on the results of in silico predictive analyses, in vitro functional assays and data from epidemiological and literature databases. Except for the sweat test value, no clear genotype-phenotype correlation was observed.

CONCLUSIONS

DB should not be considered a classical autosomal recessive CFTR-RD. Moreover, although further investigations are necessary, we proposed a new class of "Non-Neutral Variants" whose impact on lung disease requires more studies.

摘要

背景

尽管有几项综合性研究评估了囊性纤维化跨膜传导调节因子(CFTR)基因在特发性弥漫性支气管扩张(DB)中的作用,但仍存在争议。

方法

我们分析了47例DB患者和47例对照者的CFTR基因全编码区、侧翼区域及启动子。收集了DB患者的人口统计学、肺功能、放射学和微生物学数据等可用信息。对未分类的CFTR变异体进行体外功能评估。

结果

在24例DB患者和27例对照者中鉴定出CFTR变异体。根据计算机预测分析、体外功能试验结果以及流行病学和文献数据库的数据,对DB变异体进行了重新分类。除汗液试验值外,未观察到明确的基因型-表型相关性。

结论

DB不应被视为典型的常染色体隐性CFTR相关性疾病(CFTR-RD)。此外,尽管有必要进行进一步研究,但我们提出了一类新的“非中性变异体”,其对肺部疾病的影响需要更多研究。

相似文献

1
Should diffuse bronchiectasis still be considered a CFTR-related disorder?弥漫性支气管扩张症仍应被视为与囊性纤维化跨膜传导调节因子(CFTR)相关的疾病吗?
J Cyst Fibros. 2015 Sep;14(5):646-53. doi: 10.1016/j.jcf.2015.02.012. Epub 2015 Mar 18.
2
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症中囊性纤维化跨膜电导调节子通道功能障碍。
Am J Respir Crit Care Med. 2010 May 15;181(10):1078-84. doi: 10.1164/rccm.200909-1434OC. Epub 2010 Feb 18.
3
CFTR gene mutations in adults with disseminated bronchiectasis.患有弥漫性支气管扩张症的成人中的囊性纤维化跨膜传导调节因子(CFTR)基因突变
Eur J Hum Genet. 1997 May-Jun;5(3):149-55.
4
Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease.囊性纤维化跨膜电导调节因子在慢性鼻-肺疾病患者中的作用。
Chest. 2012 Oct;142(4):996-1004. doi: 10.1378/chest.11-2543.
5
Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.支气管扩张或肺部非结核分枝杆菌感染成人患者囊性纤维化跨膜传导调节因子突变的前瞻性分析。
Chest. 2006 Oct;130(4):995-1002. doi: 10.1378/chest.130.4.995.
6
CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease.哮喘、弥漫性支气管扩张和慢性阻塞性肺疾病患者的CFTR基因突变——包括三种新的核苷酸替换——及单倍型背景
Hum Genet. 2001 Mar;108(3):216-21. doi: 10.1007/s004390100467.
7
Novel cftr gene sequence variation in Serbian patient with idiopathic disseminated bronchiectasis.塞尔维亚特发性弥漫性支气管扩张症患者中新型囊性纤维化跨膜传导调节因子(CFTR)基因序列变异
Fetal Pediatr Pathol. 2010 Jan;29(2):95-8. doi: 10.3109/15513811003620815.
8
Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations?成年患者的支气管扩张:CFTR基因突变杂合性的一种表现?
Clin Genet. 2004 Jun;65(6):490-5. doi: 10.1111/j.0009-9163.2004.00265.x.
9
Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritis.支气管扩张症合并类风湿关节炎患者的囊性纤维化基因突变。
Ann Rheum Dis. 2011 Apr;70(4):653-9. doi: 10.1136/ard.2010.142760. Epub 2010 Dec 3.
10
Disrupted post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by a 5'UTR mutation is associated with a CFTR-related disease.由 5'UTR 突变引起的囊性纤维化跨膜电导调节因子(CFTR)转录后调控紊乱与 CFTR 相关疾病有关。
Hum Mutat. 2011 Oct;32(10):E2266-82. doi: 10.1002/humu.21545.

引用本文的文献

1
Cystic Fibrosis Carrier States Are Associated With More Severe Cases of Bronchiectasis.囊性纤维化携带者状态与更严重的支气管扩张病例相关。
Open Forum Infect Dis. 2024 Jan 17;11(2):ofae024. doi: 10.1093/ofid/ofae024. eCollection 2024 Feb.
2
Identification of cystic fibrosis transmembrane conductance regulator gene (CFTR) variants: A retrospective study on the western and southern regions of Saudi Arabia.鉴定囊性纤维化跨膜电导调节因子(CFTR)基因变异:对沙特阿拉伯西部地区和南部地区的回顾性研究。
Saudi Med J. 2023 Oct;44(10):987-994. doi: 10.15537/smj.2023.44.10.20230290.
3
Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?
与卵母细胞和精子供体进行高风险基因匹配的概率:全基因分析还是基因分型检测?
J Assist Reprod Genet. 2022 Feb;39(2):341-355. doi: 10.1007/s10815-021-02381-0. Epub 2022 Jan 29.
4
The Effect of Synonymous Single-Nucleotide Polymorphisms on an Atypical Cystic Fibrosis Clinical Presentation.同义单核苷酸多态性对非典型囊性纤维化临床表现的影响。
Life (Basel). 2020 Dec 27;11(1):14. doi: 10.3390/life11010014.
5
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways.CFTR 靶向治疗:囊性纤维化的最新进展及在其他气道疾病中的可能性。
Eur Respir Rev. 2020 Jun 16;29(156). doi: 10.1183/16000617.0068-2019. Print 2020 Jun 30.
6
Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis.SLC26A9氯离子通道在囊性纤维化中作为疾病修饰因子和潜在治疗靶点的作用
Front Pharmacol. 2018 Oct 1;9:1112. doi: 10.3389/fphar.2018.01112. eCollection 2018.
7
Screening for Regulatory Variants in 460 kb Encompassing the CFTR Locus in Cystic Fibrosis Patients.筛查囊性纤维化患者 CFTR 基因座 460kb 范围内的调控变异。
J Mol Diagn. 2019 Jan;21(1):70-80. doi: 10.1016/j.jmoldx.2018.08.011. Epub 2018 Oct 5.
8
In Defense of Lady Windermere Syndrome.《为温德米尔夫人的扇子综合征辩护》
Lung. 2018 Aug;196(4):377-379. doi: 10.1007/s00408-018-0122-x. Epub 2018 May 15.
9
Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis.非囊性纤维化相关支气管扩张症的病理生理学和遗传学。
Lung. 2018 Aug;196(4):383-392. doi: 10.1007/s00408-018-0121-y. Epub 2018 May 12.
10
The therapeutic potential of CFTR modulators for COPD and other airway diseases.CFTR 调节剂在 COPD 和其他气道疾病中的治疗潜力。
Curr Opin Pharmacol. 2017 Jun;34:132-139. doi: 10.1016/j.coph.2017.09.013. Epub 2017 Nov 10.